1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Fenton, Michigan. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Fenton.
Fenton, Michigan has 1 SAMHSA-verified addiction treatment center offering 1 residential rehab, 1 dual diagnosis, 1 detox. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Residential treatment programs in Fenton provide 24/7 structured care in a substance-free environment. These programs typically last 30 to 90 days and include individual therapy, group counseling, and life skills training.
Treatment centers in Fenton accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Withdrawal severity is the first clinical screening factor for treatment entry in Fenton. Patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care — untreated severe alcohol withdrawal carries 5% mortality and severe benzodiazepine withdrawal can be fatal. Opioid use patients face a different pathway: detox-only is rarely effective for opioid use disorder, and evidence-based protocols typically initiate medication-assisted treatment (buprenorphine or methadone) during the stabilization phase.
Depression co-occurs with substance use disorders at high rates and is often a treatment-complicating factor for Fenton patients. Substance use can mask depressive symptoms, withdrawal can produce transient depression, and protracted post-acute withdrawal syndrome (PAWS) can extend depressive episodes well past acute detox. Quality Fenton programs distinguish primary depression (preceded substance use) from substance-induced depression (would resolve with sustained abstinence) and treat accordingly — psychiatric medication management for the former, watchful waiting plus behavioral activation for the latter.
Pregnant women in Fenton with active substance use should not stop opioid use abruptly if dependent — withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. Michigan maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and SAMHSA's Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways for this population.
The addiction-treatment landscape in Fenton, Michigan, reflects the broader epidemiology of substance use in the region: alcohol use disorder remains the most prevalent diagnosis at treatment intake nationally, opioid use disorder presents the highest overdose mortality, stimulant use disorder is increasingly common (cocaine and methamphetamine), and polysubstance use is the rule rather than the exception. Fenton providers structure programs to address this diversity — most treat the full range of substance-use disorders within an integrated clinical framework rather than maintaining substance-specific tracks.
The first 90 days post-discharge are the highest-relapse-risk window for Fenton patients leaving residential treatment — multiple studies place 60-70% of relapses within this window. Structured continuity matters: same-team outpatient continuity, scheduled check-ins, structured-day expectations, and mutual-support engagement reduce 90-day relapse risk substantially compared to discharge-and-good-luck approaches. Programs that build this continuity into their model report measurably better outcomes than those treating discharge as the program endpoint.
Cost expectations for Fenton residential addiction treatment span a wide range: standard 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 in pre-insurance billing; premium or specialty programs (luxury, executive, specialized clinical focus) can run $30,000-$70,000+. With in-network commercial insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
The intake process at most Fenton residential programs begins with a comprehensive clinical assessment covering substance-use history (substance, quantity, duration, last use, withdrawal history), mental-health history, physical-health status (including medications and chronic conditions), social context (housing, employment, family, legal), and recovery history (prior treatment episodes, what worked, what didn't). The assessment typically takes 60-90 minutes and produces an initial treatment plan within 72 hours.